 |
市場調查報告書
商品編碼
2054278
寵物糖尿病照護設備市場：依動物種類、解決方案、最終使用者和地區分類Pet Diabetes Care Devices Market, By Animal Type, By Solutions, By End User, By Geography |
||||||
2026年寵物糖尿病護理設備市場規模估計為28億美元，預計2033年將達到46.4億美元。預計2026年至2033年，該市場將以7.5%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 28億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 7.50% | 2033年市場規模預測： | 46.4億美元 |
近年來，全球寵物糖尿病護理設備市場經歷了顯著成長。寵物肥胖率的上升以及寵物日益“擬人化”，促使人們對寵物健康、預防保健和疾病治療的關注度不斷提高。寵物飼主積極監測寵物的血糖值，並透過胰島素和治療性飲食來控制寵物的糖尿病。多種技術已被開發出來，用於實現寵物糖尿病管理的非侵入性監測和胰島素給藥。持續血糖監測（CGM）系統、胰島素幫浦和採血設備的進步簡化了寵物糖尿病的照護。寵物保險覆蓋範圍的擴大和寵物護理支出的增加也推動了對專業寵物糖尿病護理設備的需求。然而，設備和治療的高成本仍然是限制市場成長的主要挑戰。
市場動態
推動全球寵物糖尿病護理設備市場成長的關鍵因素包括寵物肥胖率上升、開發中國家寵物飼養量增加、寵物健康和疾病管理意識增強、新產品上市以及技術進步。然而，血糖值監測設備、治療和獸醫護理的高成本是這些技術廣泛應用的主要障礙。市場參與企業正致力於透過創新開發價格合理的解決方案，以擴大其在開發中地區的基本客群。寵物護理新創企業創業投資的增加表明，開發新解決方案和進入尚未開發的市場蘊藏著巨大的機會。
本次調查的主要特點
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數對全球寵物糖尿病護理設備市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份全球寵物糖尿病護理設備市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用分析全球寵物糖尿病護理設備市場中使用的各種策略矩陣，更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場概覽
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
第4章 全球寵物糖尿病照護設備市場：依動物類型分類，2026-2033年
- 狗
- 貓
第5章 全球寵物糖尿病護理設備市場：依解決方案分類，2026-2033年
- 過程
- 胰島素治療
- 血糖值測量裝置
第6章 全球寵物糖尿病護理設備市場：依最終用戶分類，2026-2033年
- 動物診所
- 居家醫療
- 動物醫院
第7章 全球寵物糖尿病照護設備市場：依地區分類，2026-2033年
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第8章 競爭情勢
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol SA
- i-SENS, Inc.
第9章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第10章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
Pet Diabetes Care Devices Market is estimated to be valued at USD 2.80 Bn in 2026 and is expected to reach USD 4.64 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.80 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.50% | 2033 Value Projection: | USD 4.64 Bn |
The global pet diabetes care devices market has been witnessing significant growth in the recent times. Rising pet obesity levels and increasing pet humanization have resulted in greater awareness about pet health, preventive care, and treatment of pet diseases. Pet owners are making active efforts towards monitoring blood glucose levels and managing diabetes in pets through insulin administration and therapeutic diet. Various technologies have been developed for diabetes management in pets which enables the non-invasive monitoring and administration of insulin doses. Advancements in continuous glucose monitoring (CGM) systems, insulin pumps, and lancing devices have simplified diabetes care for pets. Growing pet insurance coverage and rising pet care expenditure also supports the demand for specialized pet diabetes care devices. However, high cost of devices and therapy remains a key challenge for market growth.
Market Dynamics
Key factors, such as rising pet obesity, growing pet ownership in developing nations, increasing awareness about pet health and disease management, new product launches, and technological advancements, are fueling the growth of global pet diabetes care devices market. However, high cost associated with glucose monitoring devices, therapy and veterinary care is a major factor hampering the widespread adoption of these technologies. Market players are focusing on developing affordable solutions through innovations to expand their customer base in developing regions. Rising venture capital funding in pet care startups indicate strong opportunities for development of novel solutions as well as penetration in untapped markets.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pet diabetes care devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services, Inc, Roche Diagnostics, Bio-Rad Laboratories, Inc, Novo Nordisk A/S, Zoetis Inc, Terumo Corporation, Boehringer Ingelheim International GmbH, IDEXX Laboratories, Johnson & Johnson Services, Inc, Terumo Corporation, Eli Lilly and Company, Vetoquinol S.A., i-SENS, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pet diabetes care devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pet diabetes care devices market.
Market Segmentation
- By Animal Type (Revenue, USD Bn, 2021 - 2033)
- Dogs
- Cats
- By Solutions (Revenue, USD Bn, 2021 - 2033)
- Treatment
- Insulin Therapy
- Insulin Delivery Devices
- Other Treatments
- Glucose Monitoring Devices
- By End User (Revenue, USD Bn, 2021 - 2033)
- Veterinary Clinics
- Home Care Settings
- Veterinary Hospitals
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
- i-SENS, Inc.
Table of Contents
1. Research objectives and assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Pet Diabetes Care Devices Market, By Animal Type
- Global Pet Diabetes Care Devices Market, By Solutions
- Global Pet Diabetes Care Devices Market, By End User
- Global Pet Diabetes Care Devices Market, By Region
3. Market dynamics, regulations, and trends analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Pet Diabetes Care Devices Market, By Animal Type, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
5. Global Pet Diabetes Care Devices Market, By Solutions, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Insulin Therapy
- Insulin Delivery Devices
- Other Treatments
- Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
6. Global Pet Diabetes Care Devices Market, By End User, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
7. Global Pet Diabetes Care Devices Market, By Region, 2026 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2026 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- U.S.
- Canada
- Introduction
- Latin America
- Introduction
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Introduction
- Europe
- Introduction
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Introduction
- Asia Pacific
- Introduction
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Introduction
- Middle East
- Introduction
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
- Africa
- Introduction
- South Africa
- North Africa
- Central Africa
- Introduction
8. COMPETITIVE LANDSCAPE
- Abbot Laboratories, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zoetis Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDEXX Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetoquinol S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- i-SENS, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
